Sangamo Therapeutics (SGMOQ) Exchange Rate Effect (2018 - 2025)
Sangamo Therapeutics (SGMOQ) posted Exchange Rate Effect of $40000.0 for Q4 2025, down 4.76% on a QoQ basis from $42000.0 in Q3 2025, and up 101.78% year-over-year from $19823.6 in Q4 2024.
Powered by 
Analysis
Sangamo Therapeutics (SGMOQ) Exchange Rate Effect (2018 - 2025) Analysis & Trends
Sangamo Therapeutics has reported Exchange Rate Effect for 8 years, with the latest figure at $40000.0 in Q4 2025.
- On a quarterly basis, Exchange Rate Effect rose 101.78% year-over-year to $40000.0 in Q4 2025; TTM through Dec 2025 was $4.1 million, a 299.76% increase from a year earlier, with the FY2025 full-year figure at $4.1 million, up 299.76% from the prior year.
- Exchange Rate Effect was $40000.0 for Q4 2025 at Sangamo Therapeutics, down from $42000.0 in the prior quarter.
- The five-year high for Exchange Rate Effect was $2.7 million in Q2 2025, with the low at -$2.2 million in Q4 2024.
- Average Exchange Rate Effect over 5 years is $225850.0, with a median of $128500.0 recorded in 2022.
- The sharpest annual moves came in 2023 and 2025: Exchange Rate Effect sank 533.07% in 2023, then jumped 1163.04% in 2025.
- Over 5 years, Exchange Rate Effect stood at -$115000.0 in 2021, then soared by 773.91% to $775000.0 in 2022, then surged by 74.58% to $1.4 million in 2023, then plunged by 266.08% to -$2.2 million in 2024, then jumped by 101.78% to $40000.0 in 2025.
- The last three Exchange Rate Effect figures came in at $40000.0 (Q4 2025), $42000.0 (Q3 2025), and $2.7 million (Q2 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.26 Bn | 9.41 Bn | 112.79 Mn | -1.83 Mn |
| 2 | CRISPR Therapeutics AG | 5.19 Bn | 5.19 Bn | - | 6,000.00 |
| 3 | Iovance Biotherapeutics | 3.76 Bn | 3.46 Bn | 55.72 Mn | -124,000.00 |
| 4 | Legend Biotech | 3.67 Bn | 2.71 Bn | 251.50 Mn | -300,000.00 |
| 5 | uniQure | 3.09 Bn | 3.09 Bn | 5.49 Mn | -774,000.00 |
| 6 | Beam Therapeutics | 2.67 Bn | 2.67 Bn | - | - |
| 7 | Precigen | 2.43 Bn | 2.43 Bn | 52.17 Mn | 1,000.00 |
| 8 | Sarepta Therapeutics | 2.33 Bn | 1.54 Bn | 251.87 Mn | - |
| 9 | Vericel | 1.99 Bn | 1.83 Bn | 56.40 Mn | - |
| 10 | Sangamo Therapeutics | 43.15 Mn | 22.20 Mn | - | 40,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 40,000.00 |
| Sep 30, 2025 | 42,000.00 |
| Jun 30, 2025 | 2.73 Mn |
| Mar 31, 2025 | 1.28 Mn |
| Dec 31, 2024 | -2.25 Mn |
| Sep 30, 2024 | 1.13 Mn |
| Jun 30, 2024 | -257,000.00 |
| Mar 31, 2024 | -670,000.00 |
| Dec 31, 2023 | 1.35 Mn |
| Sep 30, 2023 | -550,000.00 |
| Jun 30, 2023 | 313,000.00 |
| Mar 31, 2023 | 367,000.00 |
| Dec 31, 2022 | 775,000.00 |
| Sep 30, 2022 | 127,000.00 |
| Jun 30, 2022 | 130,000.00 |
| Mar 31, 2022 | 222,000.00 |
| Dec 31, 2021 | -115,000.00 |
| Sep 30, 2021 | 28,000.00 |
| Jun 30, 2021 | 152,000.00 |
| Mar 31, 2021 | -328,000.00 |